In vitro safety “clinical trial” of the cardiac liability of drug polytherapy

Only a handful of US Food and Drug Administration (FDA) Emergency Use Authorizations exist for drug and biologic therapeutics that treat severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) infection. Potential therapeutics include repurposed drugs, some with cardiac liabilities. We report o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Transl Sci
Egile Nagusiak: Charrez, Bérénice, Charwat, Verena, Siemons, Brian, Finsberg, Henrik, Miller, Evan W., Edwards, Andrew G., Healy, Kevin E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2021
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8212738/
https://ncbi.nlm.nih.gov/pubmed/33786981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.13038
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak